| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |